These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7941961)

  • 21. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
    Coryell W; Turner RD; Sherman A
    J Clin Psychopharmacol; 1987 Jun; 7(3):138-42. PubMed ID: 3298326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ; Kocsis JH; Ritvo EC; Cutler RB
    JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desipramine for the treatment of "pure" dysthymia versus "double" depression.
    Marin DB; Kocsis JH; Frances AJ; Parides M
    Am J Psychiatry; 1994 Jul; 151(7):1079-80. PubMed ID: 8010368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring S-adenosyl-methionine blood levels and antidepressant effect.
    Del Vecchio M; Amati A; Vacca L; Zizolfi S
    Acta Neurol (Napoli); 1980 Dec; 2(6):488-95. PubMed ID: 7027755
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 34. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of depression to very high plasma levels of imipramine plus desipramine.
    Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB
    Biol Psychiatry; 1991 Jul; 30(1):57-62. PubMed ID: 1892963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
    Peet M; Horrobin DF
    Arch Gen Psychiatry; 2002 Oct; 59(10):913-9. PubMed ID: 12365878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical correlations of one-carbon metabolism abnormalities.
    Tolbert LC; Monti JA; Walter-Ryan W; Alarcon RD; Bahar B; Keriotis JT; Allison JG; Cates A; Antun F; Smythies JR
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):491-502. PubMed ID: 3406427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective complaints during desipramine treatment. Relative importance of plasma drug concentrations and the severity of depression.
    Nelson JC; Jatlow PI; Quinlan DM
    Arch Gen Psychiatry; 1984 Jan; 41(1):55-9. PubMed ID: 6691785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.